Do gut microbiome-targeted therapies improve liver function in cirrhotic patients? A systematic review and meta-analysis.

Journal of gastroenterology and hepatology(2023)

Cited 0|Views1
No score
Abstract
MTTs appeared to be associated with a slowed deterioration in liver cirrhosis, which could provide reference for clinicians in treatment of cirrhotic patients based on their conditions.
More
Translated text
Key words
Gut microbiome, Liver cirrhosis, Liver function, Meta-analysis, Microbiome-targeted therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined